Defining subsets of lung cancer to optimise therapeutic approaches

patientpower has 2382 videos Subscribe Here

Description: At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Prof Pasi A. Jänne, from Dana-Farber Cancer Institute, Boston, MA, discusses the development of targeted therapies and immunotherapies for different patient subsets of lung cancer. Although both types of approaches have shown successful results, they raise more questions and challenges, such as the need to identify patient subsets that are likely to respond to individual therapeutic interventions.

Visit our website |
Follow on Twitter |
Like on Facebook |
Shared By : patientpower
Posted on : 01/27/16
Added : 2 years ago


Nothing found.